Loading…
AtriCure, Inc. is projected to rise to $49.96 by 2027, a +24% move from its current price of $40.15. ATRC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $39.05 | $40.18 | $41.34 | +0.07% |
| Aug 2 | $38.62 | $40.21 | $41.86 | +0.14% |
| Aug 3 | $38.30 | $40.23 | $42.27 | +0.21% |
| Aug 4 | $38.03 | $40.26 | $42.62 | +0.28% |
| Aug 5 | $37.80 | $40.29 | $42.93 | +0.34% |
| Aug 6 | $37.60 | $40.32 | $43.23 | +0.41% |
| Aug 7 | $37.42 | $40.34 | $43.50 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $37.42 | $40.34 | $43.50 | +0.48% |
| Week 2 | $36.44 | $40.54 | $45.09 | +0.97% |
| Week 3 | $35.75 | $40.73 | $46.41 | +1.45% |
| Week 4 | $35.21 | $40.93 | $47.58 | +1.94% |
| Week 5 | $34.76 | $41.13 | $48.67 | +2.44% |
| Week 6 | $34.37 | $41.33 | $49.69 | +2.93% |
| Week 7 | $34.03 | $41.53 | $50.68 | +3.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AtriCure, Inc. is a healthcare company that develops, manufactures, and sells devices for the surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves. It serves medical centers in the United States, the Asia-Pacific, and internationally.
Its portfolio includes Isolator Synergy Ablation System clamps, a range of single-use disposable radio frequency products, cryoICE Cryoablation System, EPi-Sense Systems, LARIAT System, AtriClip System, cryoSPHERE probe, cryoXT probes, Subtle Cannula's, Glidepath guides, Lumitip dissectors, and other instruments, as well as reusable cardiac surgery instruments. The company markets through independent distributors and direct sales personnel. It was incorporated in 2000 and is headquartered in Mason, Ohio.
AtriCure, Inc. (ATRC) operates in the healthcare sector with a focus on cardiac ablation devices and related surgical solutions. Its product lines span both disposable and capital equipment used in surgical and electrophysiology settings. The current price and market metrics provide a snapshot of the stock’s standing in the market.
The asset’s current price is $40.89, with a market cap of $2.08B. It is ranked 2012. The price outlook, based on the provided long-range forecast, shows bullish potential with a steady path of upside across multiple years.
The forecast presents a sequence of rising averages and corresponding price targets, with 2026 avg $40.89 rising through 2030 to $85.62, 2040 to $334.61, and 2050 to $776.24, alongside rising max values and strong ROI projections (e.g., 109.4% by 2030 and 1798.3% by 2050).
A major floor 44.5% below — a decisive break under it would weaken the trend.
The nearest floor, 32.5% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 24.1% above — clearing it would confirm fresh momentum.
Key ATRC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATRC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.64 | Buy | $38.82 | Buy |
| MA 10 | $36.40 | Buy | $37.20 | Buy |
| MA 20 | $35.14 | Buy | $35.22 | Buy |
| MA 50 | $30.86 | Buy | $32.39 | Buy |
| MA 100 | $29.77 | Buy | $31.60 | Buy |
| MA 200 | $33.13 | Buy | $32.18 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.28 | Sell |
| Stoch RSI (14) | 81.52 | Sell |
| CCI (20) | 184.67 | Buy |
| Williams %R (14) | -9.38 | Info |
| MACD (12,26,9) | 0.51 | Buy |
| ROC (12) | 16.99 | Buy |
| Bollinger %B (20,2) | 1.01 | Sell |
| Stochastic %K (14) | 90.62 | Sell |
| TRIX (15) | 0.88 | Buy |
| Awesome (5,34) | 6.24 | Buy |
| Ultimate (7,14,28) | 75.28 | Sell |
| Momentum (10) | 4.53 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 41.43 | Sell |
| ADX (14) | 31.06 | Buy |
| ATR (14) | 0.98 | Info |
The 30-day technical picture is bullish. RSI14 sits at 80, signaling strong momentum within the near term. The stock’s price is currently trading above both key moving averages, with SMA50 at $30.63 and SMA200 at $33.11.
Support is identified at $27.12 and resistance at $40.89, painting a clear near-term ceiling. The 30-day price range spans from $33.76 to $49.53, indicating room for upside within a defined band before a potential pullback or breakout.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $25.86 | $40.15 | $57.97 | 0% | Neutral | |
| $39.69 | $49.96 | $66.59 | +24% | Bullish | |
| $45.75 | $59.32 | $82.19 | +48% | Bullish | |
| $54.84 | $72.87 | $104.07 | +81% | Bullish | |
| $61.39 | $83.34 | $122.08 | +108% | Bullish | |
| $81.65 | $113.04 | $169.29 | +182% | Bullish | |
| $94.81 | $133.68 | $204.18 | +233% | Bullish | |
| $99.99 | $143.43 | $223.03 | +257% | Bullish | |
| $114.60 | $167.08 | $264.12 | +316% | Bullish | |
| $114.77 | $169.95 | $272.78 | +323% | Bullish | |
| $202.09 | $321.25 | $549.55 | +700% | Bullish | |
| $413.19 | $742.48 | $1,393.31 | +17.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $25.86 | $40.15 | $46.90 | +0.00% |
| August 2026 | $36.00 | $42.28 | $50.86 | +5.31% |
| September 2026 | $36.08 | $42.75 | $52.14 | +1.10% |
| October 2026 | $36.48 | $43.53 | $53.67 | +1.83% |
| November 2026 | $37.95 | $45.55 | $56.66 | +4.64% |
| December 2026 | $38.31 | $46.22 | $57.97 | +1.48% |
Click any year to see its month-by-month ATRC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
AtriCure, Inc.'s 2026 outlook centres on $40.15, within a $25.86 to $57.97 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, ATRC could reach as high as $66.59, with a base case around $49.96 and support toward $39.69 — roughly +24% from $40.15. Momentum favours further upside here.
Expect ATRC to range from $45.75 to $82.19 through 2028. The $59.32 average target implies a +48% move from current prices. That is up +19% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The ATRC price prediction for 2029 points to an average of $72.87 (low $54.84, high $104.07) — a potential gain of +81% on today's $40.15. Momentum favours further upside here.
In 2030, ATRC is projected to trade between $61.39 and $122.08, averaging $83.34 — a potential gain of +108% from today's $40.15. That is up +14% on the projected 2029 average. Buyers look set to stay in control over this stretch.
AtriCure, Inc.'s 2031 outlook centres on $113.04, within a $81.65 to $169.29 range. That is up +36% on the projected 2030 average. That marks a +182% change versus current levels. Momentum favours further upside here.
By 2032, ATRC could reach as high as $204.18, with a base case around $133.68 and support toward $94.81 — roughly +233% from $40.15. Buyers look set to stay in control over this stretch.
Expect ATRC to range from $99.99 to $223.03 through 2033. The $143.43 average target implies a +257% move from current prices. That is up +7% on the projected 2032 average. Momentum favours further upside here.
The ATRC price prediction for 2034 points to an average of $167.08 (low $114.60, high $264.12) — a potential gain of +316% on today's $40.15. Buyers look set to stay in control over this stretch.
In 2035, ATRC is projected to trade between $114.77 and $272.78, averaging $169.95 — a potential gain of +323% from today's $40.15. That is up +2% on the projected 2034 average. Momentum favours further upside here.
AtriCure, Inc.'s 2040 outlook centres on $321.25, within a $202.09 to $549.55 range. That is up +89% on the projected 2035 average. That marks a +700% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, ATRC could reach as high as $1,393.31, with a base case around $742.48 and support toward $413.19 — roughly +17.5x from $40.15. Momentum favours further upside here.
Investing $1,000 in ATRC today (≈ 24.9066 ATRC) could be worth
$18,492.67
+$17,492.67 (+1749%) by 2050 · US Dollar
Based on the average projected ATRC price of $742.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATRCwould be worth at today's price.
$1,000 invested in ATRC on Jul 30, 2025 (≈ 28.465698 ATRC) would be worth
$1,142.9
+$142.9 (+14.3%) today · 1.14× · US Dollar
Based on a ATRC entry price of $35.13 vs. today's $40.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33 | $1,216.67 | +21.7% |
| 1 month ago | $27.98 | $1,434.95 | +43.5% |
| 3 months ago | $29.02 | $1,383.53 | +38.4% |
| 6 months ago | $36.93 | $1,087.19 | +8.7% |
| 1 year ago | $35.13 | $1,142.9 | +14.3% |
| All time (5.0y) ago | $84.25 | $476.56 | -52.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATRC forecast.
Our base-case forecast reaches $80.00 around 2030.
Implied market cap at $80.00: $4.07B
The multi-year forecast shows continued bullish sentiment across the horizon. In 2026, the average price is $40.89 with a min of $25.86 and a max of $59.24, and the sentiment is Neutral. By 2027, the average rises to $50.97 (min $40.40, max $68.14) with a bullish tilt and a 24.7% ROI.
The path remains upward through 2028 ($60.70 avg, min $46.68, max $84.42; 48.4% ROI) and 2029 ($74.68 avg, min $56.01, max $107.12; 82.7% ROI).
By 2030, the avg price is $85.62 (min $62.81, max $126.01) with a 109.4% ROI and bullish sentiment. The forecast continues higher in subsequent years, with 2031 avg $116.76, 2032 avg $138.09, 2033 avg $148.16, 2034 avg $173.00, and 2035 avg $175.47, all carrying bullish sentiment and rising price tracks. By 2040, the avg is $334.61 (min $208.69, max $576.53) with a 718.3% ROI, and by 2050 the avg reaches $776.24 (min $426.54, max $1,469.08) and a 1798.3% ROI.
These are estimates and not guarantees. The forecast reflects model projections across a wide range of scenarios, and actual results may differ due to market conditions, execution, and other factors. The data also shows substantial long-horizon upside but with inherent uncertainty and volatility implied by the numbers throughout the forecast.
Tap a question to reveal the answer.
Avg $85.62, with a min $62.81 and a max $126.01; ROI 109.4%; sentiment bullish.
The forecast shows bullish sentiment across the horizon with rising averages and substantial upside by 2040 and 2050. For example, avg rises to $85.62 by 2030 and to $776.24 by 2050, with ROI reaching 109.4% by 2030 and 1798.3% by 2050.
Yes. The forecasted average price reaches $116.76 in 2031, indicating a crossing of $100 around that time (2030 at $85.62; 2031 at $116.76).
Low $33.76, High $49.53.
AtriCure, Inc. Community Discussion
0Share your AtriCure, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.